Jump to content
The Official Site of the Vancouver Canucks
Canucks Community

Coronavirus outbreak


CBH1926

Recommended Posts

B.C. COVID-19 pandemic update:

 

As of Tuesday, Oct. 26, 2021, 89.6% (4,155,181) of eligible people 12 and older in B.C. have received their first dose of COVID-19 vaccine and 84.5% (3,918,385) have received their second dose.

 

In addition, 90.1% (3,896,273) of all eligible adults in B.C. have received their first dose and 85.2% (3,683,380) have received their second dose.

 

B.C. is reporting 457 new cases of COVID-19, including 12 epi-linked cases, for a total of 202,973 cases in the province.

 

There are 4,829 active cases of COVID-19 in the province, and 195,646 people who tested positive have recovered. Of the active cases, 390 individuals are in hospital and 155 are in intensive care. The remaining people are recovering at home in self-isolation.

 

Note: Intensive care numbers are a subset of the total in hospital. They are not in addition to the number of people in hospital.

 

The new/active cases include:

  • 176 new cases in Fraser Health
    • Total active cases: 2,002
  • 61 new cases in Vancouver Coastal Health
    • Total active cases: 670
  • 83 new cases in Interior Health
    • Total active cases: 642
  • 82 new cases in Northern Health
    • Total active cases: 877
  • 55 new cases in Island Health
    • Total active cases: 579
  • no new cases of people who reside outside of Canada
    • Total active cases: 59

In the past 24 hours, two new deaths have been reported in the Fraser Health and Northern Health regions, for an overall total of 2,131.

 

There have been no new health-care facility outbreaks. The outbreak at Evergreen Manor (Fraser Health) has been declared over, for a total of 28 active outbreaks, including:

long-term care:

  • Willingdon Care Centre, Westminster House, Magnolia Gardens, Manoah Manor, Cherington Place, West Shore Laylum, Queens Park Care Centre, Heritage Village, Valleyhaven Retirement Community (Fraser Health);
  • Amica Lions Gate, Amica Edgemont (Vancouver Coastal Health);
  • Cottonwoods Care Centre, Overlander, Village by the Station, Haven Hill Retirement Centre, Deni House (Interior Health); and
  • Wrinch Memorial Hospital (Northern Health).

acute care:

  • Mission Memorial Hospital, Chilliwack General Hospital (Fraser Health);
  • University Hospital of Northern BC, GR Baker Memorial Hospital and Bulkley Valley District Hospital (Northern Health).

assisted or independent living:

  • Sunset Manor, Menno Terrace West, The Emerald at Elim Village, Swedish Assisted Living Residence, Harrison Pointe and Norman Manor (Fraser Health).

From Oct. 18-24, people not fully vaccinated accounted for 64.1% of cases.


From Oct. 11-24, they accounted for 76.2% of hospitalizations.

 

Past week cases (Oct. 18-24) – Total 4,181

  • Not vaccinated: 2,377 (56.9%)
  • Partially vaccinated: 300 (7.2%)
  • Fully vaccinated: 1,504 (36.0%)

Past two weeks cases hospitalized (Oct. 11-24) – Total 362

  • Not vaccinated: 252 (69.6%)
  • Partially vaccinated: 24 (6.6%)
  • Fully vaccinated: 86 (23.8%)

Past week, cases per 100,000 population after adjusting for age (Oct. 18-24)

  • Not vaccinated: 288.8
  • Partially vaccinated: 95.1
  • Fully vaccinated: 35.2

Past two weeks, cases hospitalized per 100,000 population after adjusting for age (Oct. 11-24)

  • Not vaccinated: 44.9
  • Partially vaccinated: 10.9
  • Fully vaccinated: 1.9

Since December 2020, the Province has administered 8,171,136 doses of Pfizer-BioNTech, Moderna and AstraZeneca COVID-19 vaccines.

 

https://news.gov.bc.ca/releases/2021HLTH0066-002045

  • Thanks 1
Link to comment
Share on other sites

US is set to approve.  Shots in arms before Christmas.  Canada will be right behind.

 

 

https://www.cnbc.com/2021/10/26/fda-panel-recommends-pfizers-low-dose-covid-vaccine-for-kids-ages-5-to-11.html

FDA panel recommends Pfizer’s low-dose Covid vaccine for kids ages 5 to 11

  • A key FDA advisory committee on Tuesday recommended a lower dose of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11.
  • The vote was nearly unanimous with 17 members backing it and one abstention.
  • The endorsement was a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.
  • The agency doesn’t always follow the advice of its independent committee, but it often does.

A key Food and Drug Administration advisory committee on Tuesday recommended a lower dose of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11, a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.

The endorsement by the agency’s Vaccines and Related Biological Products Advisory Committee will now be considered by the FDA, which could issue a final decision within days. The vote was nearly unanimous, with 17 members backing it and one abstention.

 

The agency doesn’t always follow the advice of its independent committee, but it often does. Next week, a Centers for Disease Control and Prevention vaccine advisory group is expected to make its own recommendation. If it issues an endorsement and CDC Director Dr. Rochelle Walensky signs off, shots for young kids could begin immediately.

 

The Biden administration said it plans to distribute the doses as soon as it’s authorized by the FDA and CDC, which is expected to come early next month. The administration said it’s procured enough vaccine to inoculate all 28 million 5- to 11-year-olds in the U.S., and will distribute it in smaller dosing and with smaller needles to make it easier for pediatricians and pharmacists to administer to kids.

Many parents say they are anxiously awaiting the vaccine’s authorization with schools now open across the U.S. and the delta variant driving a surge in children’s cases.

Children ages 5 to 11 account for roughly 9% of all reported Covid cases in the U.S., according to data presented to the committee by the FDA on Tuesday. The number of new Covid cases in kids remains exceptionally high, with more than 1.1 million child cases added over the past six weeks, according to the American Academy of Pediatrics.

Still, some parents and advocacy groups argue Covid vaccinations for children are unnecessary as studies show kids are less likely to experience symptoms from the disease even though they get infected at similar rates as adults.

 

Some committee members said Tuesday that vaccinating younger groups would help the U.S. move toward Covid’s “endemic” phase, where the virus is still circulating but at lower levels than it is now. Others noted there are unknowns, such as the rate of myocarditis in young kids, but still emphasized that the benefits of the shots outweighed the risks. One member wondered whether they should issue a recommendation only for at-risk children.

“We don’t want children to be dying from Covid, even if it is far fewer children than adults, and we don’t want them in the ICU,” member Dr. Amanda Cohn said before the vote.

Prior to the vote, Dr. Peter Marks, the FDA’s top vaccine regulator, asked committee members to keep today’s debate “civil,” saying there were strong feelings on both sides.

“To be clear, today’s discussion is going to be about the scientific data that are presented, and it’s not about vaccine mandates, which are left to other entities outside of FDA,” Marks said at the top of the meeting. “I ask that we keep our discourse today civil and focus on the science related to this issue so that we can get through a productive discussion.”

Pfizer asked the FDA to authorize its vaccine for kids ages 5 to 11 on Oct. 7. The company published data that showed a two-dose regimen of 10 micrograms — a third of the dosage used for teens and adults — is safe and generated a strong immune response in a clinical trial of young children. It said the shots were well tolerated and produced an immune response and side effects comparable with those seen in a study of people ages 16 to 25.

Dr. Doran Fink, a deputy director of the FDA’s division of vaccines, said Tuesday a “small army” of FDA staff worked around the clock over the last month to ensure the data on kids they were presenting today was as accurate as possible.

The staff of the FDA published an analysis late Friday, saying a smaller dosage of the Pfizer vaccine appears to be safe and highly effective in young kids. They noted the increased risk of myocarditis and pericarditis but said the benefits of the shots, including preventing severe disease, hospitalization and death, would generally outweigh the risk of the rare inflammatory heart conditions.

There have been 1,640 cases of myocarditis reported in people under 30 who received Pfizer’s or Moderna’s Covid vaccines as of Oct. 6, Dr. Mathew Oster, a CDC official, told the FDA’s vaccine committee. Just 877 met the CDC’s case definition for myocarditis. He added the agency hasn’t seen increased rates of the condition among children ages 12 to 17.

Link to comment
Share on other sites

8 hours ago, King Heffy said:

Great news.  Hoping the third dose doesn't hit me harder than the second though.

 

I felt nothing after my third Pfizer.  My flu shot had more arm soreness. Maybe I got the saline placebo :lol:

 

I guess I can get my 4th when I visit Canada for Xmas.  J/K.

 

 

Screenshot_20211027-031911.png

  • Vintage 1
Link to comment
Share on other sites

6 hours ago, Jaimito said:

I felt nothing after my third Pfizer.  My flu shot had more arm soreness. Maybe I got the saline placebo :lol:

 

I guess I can get my 4th when I visit Canada for Xmas.  J/K.

 

 

Screenshot_20211027-031911.png

As someone posted on fb, do you even know the ingredients in the vaccine? So, I said there's always Ivermectin, bleach, or UV rays.

  • Haha 1
Link to comment
Share on other sites

Just heard the Health Minister on NW 98 talking about the unvaccinated.  He said that even though we are at nearly 90% (of those eligible) being vaccinated, those remaining 10% are filling up the hospital beds.  He said that in the under 40 group there are currently 42 people in ICU from Covid.  41 of those persons are not vaccinated.  

  • Vintage 2
Link to comment
Share on other sites

18 minutes ago, Alflives said:

Just heard the Health Minister on NW 98 talking about the unvaccinated.  He said that even though we are at nearly 90% (of those eligible) being vaccinated, those remaining 10% are filling up the hospital beds.  He said that in the under 40 group there are currently 42 people in ICU from Covid.  41 of those persons are not vaccinated.  

we need to start live streaming the ICU and getting it on to peoples facebook feeds.

  • Thanks 1
  • Vintage 2
Link to comment
Share on other sites

 

 

https://apnews.com/article/coronavirus-pandemic-technology-business-public-health-health-ddde9854faee530d6c4bc435f3e6da74

Merck agrees to let other drug makers make its COVID pill

 

LONDON (AP) — Pharmaceutical company Merck agreed to allow other drug makers to produce its COVID-19 pill, in a move aimed at helping millions of people in poorer countries get access to the potentially life-saving drug, a United Nations-backed public health organization said on Wednesday.

The Medicines Patent Pool said in a statement that it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics.

The agreement will allow the Medicines Patent Pool to grant further licenses to qualified companies who are approved to make the drug. Neither drug maker will receive royalties under the agreement for as long as the World Health Organization deems COVID-19 to be global emergency. Molnupiravir is the first pill that has been shown to treat the disease.

Charles Gore, the executive director of the Medicines Patent Pool, said the early results for molnupiravir were “compelling” and that he hoped this first voluntary licensing agreement for a COVID-19 treatment would lead to others.

Despite repeated requests from governments and health officials, no vaccine makers have agreed to a similar deal. A hub set up by WHO in South Africa intended to share messenger RNA vaccine recipes and technologies has not enticed a single pharmaceutical to join.

 

Merck has requested its pill be licensed by both the U.S. Food and Drug Administration and the European Medicines Agency, decisions that could come within weeks.

Merck reported this month that molnupiravir cut hospitalizations and deaths by half among patients with early symptoms of COVID-19. The results were so strong that independent medical experts monitoring the trial recommended stopping it early.

An antiviral pill that people could take at home to reduce their symptoms and speed recovery could prove groundbreaking, easing the crushing caseload on hospitals and helping to curb outbreaks in poorer countries with weak health care systems.

It would also bolster a two-pronged approach to the pandemic: treatment by way of medication and prevention, primarily through vaccinations.

The charity Doctors Without Borders welcomed the agreement Merck struck to share its COVID-19 pill, but said it didn’t go far enough.

“The license excludes key upper-middle-income countries like Brazil and China from its territory, where there are strong, established capacity to produce and supply antiviral medicines,” said Yuanqiong Hu, a senior legal and policy adviser at Doctors Without Borders, who called the deal “disappointing.”

  • Upvote 1
  • Vintage 1
Link to comment
Share on other sites

@Tortorella's Rant

 

https://www.washingtonpost.com/world/2021/10/27/merck-license-ip/

 

U.S. pharmaceutical giant Merck has agreed to share its license for its experimental covid-19 drug, molnupiravir, with a nonprofit organization so that it can be manufactured widely around the world in a deal that would expand access to the treatment in more than 100 countries.

  • Upvote 1
Link to comment
Share on other sites

3 minutes ago, thedestroyerofworlds said:

 

 

https://apnews.com/article/coronavirus-pandemic-technology-business-public-health-health-ddde9854faee530d6c4bc435f3e6da74

Merck agrees to let other drug makers make its COVID pill

 

LONDON (AP) — Pharmaceutical company Merck agreed to allow other drug makers to produce its COVID-19 pill, in a move aimed at helping millions of people in poorer countries get access to the potentially life-saving drug, a United Nations-backed public health organization said on Wednesday.

The Medicines Patent Pool said in a statement that it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics.

The agreement will allow the Medicines Patent Pool to grant further licenses to qualified companies who are approved to make the drug. Neither drug maker will receive royalties under the agreement for as long as the World Health Organization deems COVID-19 to be global emergency. Molnupiravir is the first pill that has been shown to treat the disease.

Charles Gore, the executive director of the Medicines Patent Pool, said the early results for molnupiravir were “compelling” and that he hoped this first voluntary licensing agreement for a COVID-19 treatment would lead to others.

Despite repeated requests from governments and health officials, no vaccine makers have agreed to a similar deal. A hub set up by WHO in South Africa intended to share messenger RNA vaccine recipes and technologies has not enticed a single pharmaceutical to join.

 

Merck has requested its pill be licensed by both the U.S. Food and Drug Administration and the European Medicines Agency, decisions that could come within weeks.

Merck reported this month that molnupiravir cut hospitalizations and deaths by half among patients with early symptoms of COVID-19. The results were so strong that independent medical experts monitoring the trial recommended stopping it early.

An antiviral pill that people could take at home to reduce their symptoms and speed recovery could prove groundbreaking, easing the crushing caseload on hospitals and helping to curb outbreaks in poorer countries with weak health care systems.

It would also bolster a two-pronged approach to the pandemic: treatment by way of medication and prevention, primarily through vaccinations.

The charity Doctors Without Borders welcomed the agreement Merck struck to share its COVID-19 pill, but said it didn’t go far enough.

“The license excludes key upper-middle-income countries like Brazil and China from its territory, where there are strong, established capacity to produce and supply antiviral medicines,” said Yuanqiong Hu, a senior legal and policy adviser at Doctors Without Borders, who called the deal “disappointing.”

damn you, you stole my thunder 

  • Cheers 1
  • Haha 1
Link to comment
Share on other sites

1 hour ago, JM_ said:

@Tortorella's Rant

 

https://www.washingtonpost.com/world/2021/10/27/merck-license-ip/

 

U.S. pharmaceutical giant Merck has agreed to share its license for its experimental covid-19 drug, molnupiravir, with a nonprofit organization so that it can be manufactured widely around the world in a deal that would expand access to the treatment in more than 100 countries.

No word on measures to alleviate the horse dewormer shortage?

 

  • Haha 2
Link to comment
Share on other sites

3 hours ago, JM_ said:

we need to start live streaming the ICU and getting it on to peoples facebook feeds.

THIS ^^^^...times infinity.

Let me tell you.... the reality of having Covid,... being intubated and in ICU for a length of time plus all the indignities and gross-out things that will happen to you including the diapers you'll be wearing 'might' help sway a person or two....there ain't NOTHING pretty or nice that is going to be happening to you if you end up there.

  • Wat 1
  • Upvote 1
  • Vintage 1
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...